Division of Cardiology Department of Internal Medicine Heart Vascular Stroke InstituteSamsung Medical CenterSungkyunkwan University School of Medicine Seoul South Korea.
Department of Obstetrics and Gynecology Korea University College of Medicine Seoul South Korea.
J Am Heart Assoc. 2022 Jan 18;11(2):e023013. doi: 10.1161/JAHA.121.023013. Epub 2022 Jan 11.
Background Although pregnancy-induced hypertension (PIH) is associated with an elevated cardiovascular risk, long-term studies or prepregnancy baseline data are scarce. Therefore, using a large nationwide cohort with prepregnancy periodic health screening data, we investigated whether clinically significant arrhythmia incidence increases after PIH. Methods and Results Data were extracted from the Korea National Health Insurance database and combined with the National Health Screening Examination database; women who gave birth between 2007 and 2015 and underwent the national health screening test within a year before pregnancy were followed up until 2016. We excluded women who had a diagnosis of arrhythmia within 1 year before pregnancy. The primary outcome was significant arrhythmia during the year after delivery. Secondary analysis included only specific diagnostic codes of arrhythmia with clinical significance. Additionally, the risk of arrhythmia was stratified by the use of magnesium sulfate. Of 2 035 684 women (PIH; n=37 297 versus normotensive pregnancy; n=1 998 387), the PIH group had a higher prepregnancy risk profile and showed a higher incidence of arrhythmia than women with normotensive pregnancies within 1 year. Women with PIH had a significantly higher risk of atrial flutter/fibrillation and atrioventricular block, but not lethal arrhythmias. Other predictors of arrhythmia development included advanced maternal age and cesarean section. Stratified analysis showed a higher risk of arrhythmia with magnesium sulfate use. Conclusions PIH was significantly associated with the development of arrhythmia within 1 year after delivery. Nevertheless, the incidence of lethal arrhythmias was not increased by PIH. Arrhythmia, especially atrial fibrillation, may largely contribute to increasing the future cardiovascular risk in women with a PIH history.
尽管妊娠高血压(PIH)与心血管风险升高相关,但长期研究或孕前基线数据较为缺乏。因此,我们利用一个有孕前定期健康筛查数据的大型全国队列,调查 PIH 后是否会增加临床显著心律失常的发生率。
数据来自韩国国家健康保险数据库和国家健康筛查数据库;2007 年至 2015 年分娩且在怀孕前 1 年内接受国家健康筛查的女性被随访至 2016 年。我们排除了在怀孕前 1 年内有诊断为心律失常的女性。主要结局是产后 1 年内发生显著心律失常。二次分析仅包括具有临床意义的特定心律失常诊断代码。此外,还根据硫酸镁的使用情况对心律失常风险进行分层。在 2035684 名女性(PIH:n=37297 例;正常血压妊娠:n=1998387 例)中,PIH 组的孕前风险状况较高,且在怀孕前 1 年内发生心律失常的发生率高于正常血压妊娠组。PIH 组女性发生房性扑动/颤动和房室传导阻滞的风险显著增加,但致死性心律失常的发生率没有增加。心律失常发生的其他预测因素包括高龄产妇和剖宫产。分层分析显示硫酸镁使用与心律失常风险增加相关。
PIH 与产后 1 年内心律失常的发生显著相关。然而,PIH 并未增加致死性心律失常的发生率。心律失常,特别是心房颤动,可能在很大程度上导致有 PIH 病史的女性未来心血管风险增加。